[{"from": "human", "value": "Use the given information to create a molecule that fulfills the desired purpose. The molecule is an orally available inhibitor of extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity. Upon oral administration, ulixertinib inhibits both ERK 1 and 2, thereby preventing the activation of ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is often upregulated in a variety of tumor cell types and plays a key role in tumor cell proliferation, differentiation and survival."}, {"from": "gpt", "value": "[C][C][Branch1][C][C][N][C][=N][C][=C][Branch2][Ring2][Branch1][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][=C][N][C][=Branch1][Ring2][=C][Ring1][Branch1][C][=Branch1][C][=O][N][C@H1][Branch1][Ring1][C][O][C][=C][C][=Branch1][=Branch1][=C][C][=C][Ring1][=Branch1][Cl][Cl]"}]